{
  "main_header": {
    "sid": 1002863,
    "name": "Shree Ganesh Rem",
    "stock_name": "Shree Ganesh Rem",
    "full_name": "Shree Ganesh Remedies Ltd",
    "name_url": "stocks-analysis/shree-ganesh-rem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "617.10",
    "chg": 10.65,
    "chgp": "1.76%",
    "dir": 1,
    "prev_price": "606.45",
    "mcapval": "792.21 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540737,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE414Y01015",
    "curr_date": "Aug 11",
    "curr_time": "",
    "bse_nse_vol": "20.34 k",
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/shree-ganesh-rem-1002863-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Shree Ganesh Remedies Ltd Shows Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-shows-technical-momentum-shift-amid-mixed-market-signals-4002210",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShreeGaneshReme_technicaldot_4002210.png",
        "date": "2026-05-21 08:04:07",
        "description": "Shree Ganesh Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. Despite a slight dip in the stock price on 21 May 2026, the evolving technical indicators suggest a nuanced market sentiment for this micro-cap pharmaceutical player, warranting close attention from investors and analysts alike."
      },
      {
        "title": "Golden Cross Forms in Shree Ganesh Remedies Ltd — On a Day the Stock Fell 0.66%. What the Mixed Signals Mean",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/shree-ganesh-remedies-ltd-forms-golden-cross-indicating-potential-bullish-breakout-4001420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ShreeGaneshReme_goldencross_4001420.png",
        "date": "2026-05-20 18:00:37",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Shree Ganesh Remedies Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.66% on the same day, while monthly momentum indicators remain bearish. This juxtaposition of signals invites a closer examination of the technical and fundamental context behind the crossover."
      }
    ],
    "total": 15,
    "sid": "1002863",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/shree-ganesh-remedies-1002863"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for The Unaudited (Standalone And Consolidated) Financial Results Of The Company For The Quarter Ended On June 30 2026",
      "datetime": "08-Aug-2026",
      "details": "Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended on June 30 2026",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "13-Jul-2026",
      "details": "Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Clarification On Price Movement",
      "datetime": "29-Jun-2026",
      "details": "Clarification",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Remedies Ltd has declared <strong>5%</strong> dividend, ex-date: 07 Sep 23",
          "dt": "2023-09-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Remedies Ltd has announced <strong>1:5</strong> bonus issue, ex-date: 01 Nov 21",
          "dt": "2021-11-01",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Shree Ganesh Remedies Ltd has announced <strong>7:100</strong> rights issue, ex-date: 03 Feb 23",
          "dt": "2023-02-03",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Shree Ganesh Remedies Ltd Shows Technical Momentum Shift Amid Mixed Market Signals

2026-05-21 08:04:07

Shree Ganesh Remedies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. Despite a slight dip in the stock price on 21 May 2026, the evolving technical indicators suggest a nuanced market sentiment for this micro-cap pharmaceutical player, warranting close attention from investors and analysts alike.

Read More

Golden Cross Forms in Shree Ganesh Remedies Ltd — On a Day the Stock Fell 0.66%. What the Mixed Signals Mean

2026-05-20 18:00:37

The 50-day moving average has crossed above the 200-day moving average for Shree Ganesh Remedies Ltd, signalling a golden cross on 20 May 2026. Yet, the stock declined 0.66% on the same day, while monthly momentum indicators remain bearish. This juxtaposition of signals invites a closer examination of the technical and fundamental context behind the crossover.

Read More

View All News